{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:27:35Z","timestamp":1781850455147,"version":"3.54.5"},"reference-count":70,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ghir.2014.03.006","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T13:18:13Z","timestamp":1399641493000},"page":"112-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Transcriptional and epigenetic control of IGF1R gene expression: Implications in metabolism and cancer"],"prefix":"10.1016","volume":"24","author":[{"given":"Haim","family":"Werner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rive","family":"Sarfstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2014.03.006_bb0005","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0006-291X(91)90654-P","article-title":"Analysis of the human type I insulin-like growth factor receptor promoter region","volume":"177","author":"Cooke","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ghir.2014.03.006_bb0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/dna.1992.11.43","article-title":"Cloning and characterization of the human insulin-like growth factor-I receptor gene 5\u2032-flanking region","volume":"11","author":"Mamula","year":"1992","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.ghir.2014.03.006_bb0015","first-page":"1545","article-title":"Structural and functional analysis of the insulin-like growth factor I receptor gene promoter","volume":"6","author":"Werner","year":"1992","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ghir.2014.03.006_bb0020","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0006-291X(90)91996-6","article-title":"Cloning and characterization of the proximal promoter region of the rat insulin-like growth factor I (IGF-I) receptor gene","volume":"169","author":"Werner","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ghir.2014.03.006_bb0025","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1083\/jcb.115.4.887","article-title":"An analysis of vertebrate mRNA sequences: intimations of translational control","volume":"115","author":"Kozak","year":"1991","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ghir.2014.03.006_bb0030","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1038\/onc.2011.447","article-title":"Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer","volume":"31","author":"Werner","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.ghir.2014.03.006_bb0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/MCB.17.1.427","article-title":"Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis","volume":"17","author":"O'Connor","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ghir.2014.03.006_bb0040","first-page":"2463","article-title":"The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo","volume":"55","author":"Resnicoff","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.ghir.2014.03.006_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/excr.1999.4667","article-title":"The IGF-I receptor in cancer research","volume":"253","author":"Baserga","year":"1999","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ghir.2014.03.006_bb0050","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ghir.2014.03.006_bb0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/er.2006-0001","article-title":"The role of the IGF system in cancer growth and metastasis: overview and recent insights","volume":"28","author":"Samani","year":"2007","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2014.03.006_bb0060","first-page":"3604","article-title":"Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts","volume":"14","author":"Sell","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ghir.2014.03.006_bb0065","doi-asserted-by":"crossref","first-page":"11217","DOI":"10.1073\/pnas.90.23.11217","article-title":"Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor","volume":"90","author":"Sell","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ghir.2014.03.006_bb0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/cancers2020233","article-title":"Identification of IGF-IR gene promoter binding proteins in estrogen receptor positive and ER-depleted breast cancer cells","volume":"2","author":"Sarfstein","year":"2010","journal-title":"Cancers"},{"key":"10.1016\/j.ghir.2014.03.006_bb0075","first-page":"1147","article-title":"Regulation of insulin-like growth factor I receptor gene expression by Sp1: physical and functional interactions of Sp1 at GC boxes and at a CT element","volume":"9","author":"Beitner-Johnson","year":"1995","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ghir.2014.03.006_bb0080","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1677\/joe.1.07016","article-title":"Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1","volume":"191","author":"Maor","year":"2006","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ghir.2014.03.006_bb0085","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/jme.1.01761","article-title":"The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells","volume":"35","author":"Reizner","year":"2005","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.ghir.2014.03.006_bb0090","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.ejca.2010.02.050","article-title":"HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor gene","volume":"46","author":"Aiello","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ghir.2014.03.006_bb0095","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1126\/science.1066326","article-title":"KLF6, a candidate tumor suppressor gene mutated in prostate cancer","volume":"294","author":"Narla","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ghir.2014.03.006_bb0100","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1210\/en.2004-0173","article-title":"Transcriptional activation of the insulin-like growth factor I receptor gene by the Kruppel-like factor 6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53","volume":"145","author":"Rubinstein","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2014.03.006_bb0105","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1210\/en.2007-0844","article-title":"Insulin-like growth factor-1 regulates Kr\u00fcppel-like factor-6 gene expression in a p53-dependent manner","volume":"149","author":"Bentov","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2014.03.006_bb0110","first-page":"739","article-title":"Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis","volume":"6","author":"DeGregori","year":"2006","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ghir.2014.03.006_bb0115","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/abbi.2002.2761","article-title":"Identification of novel E2F1-regulated genes by microarray","volume":"399","author":"Ma","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ghir.2014.03.006_bb0120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ghir.2009.08.001","article-title":"Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene","volume":"20","author":"Schayek","year":"2010","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2014.03.006_bb0125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1101\/gad.1363206","article-title":"Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways","volume":"20","author":"Levine","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.ghir.2014.03.006_bb0130","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.gde.2010.10.002","article-title":"New plays in the p53 theater","volume":"21","author":"Aylon","year":"2011","journal-title":"Curr. Opin. Genes Dev."},{"key":"10.1016\/j.ghir.2014.03.006_bb0135","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1073\/pnas.93.16.8318","article-title":"Wild type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene","volume":"93","author":"Werner","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ghir.2014.03.006_bb0140","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1074\/jbc.M211606200","article-title":"WT1\u2013p53 interactions in IGF-I receptor gene regulation","volume":"278","author":"Idelman","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2014.03.006_bb0145","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1210\/endo.139.3.5832","article-title":"p53 regulates IGF-I receptor expression and IGF-I induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1","volume":"139","author":"Ohlsson","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2014.03.006_bb0150","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1128\/MCB.17.3.1084","article-title":"The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal","volume":"17","author":"Prisco","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ghir.2014.03.006_bb0155","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.ejca.2011.09.014","article-title":"p53 regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy","volume":"48","author":"Attias-Geva","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ghir.2014.03.006_bb0160","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/377646a0","article-title":"Induction of the growth inhibitor IGF-binding protein 3 by p53","volume":"377","author":"Buckbinder","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2014.03.006_bb0165","first-page":"1367","article-title":"Regulation of insulin-like growth factor II P3 promoter by p53: a potential mechanism for tumorigenesis","volume":"56","author":"Zhang","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.ghir.2014.03.006_bb0170","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1038\/sj.onc.1203015","article-title":"Regulation of p53 in response to DNA damage","volume":"18","author":"Lakin","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.ghir.2014.03.006_bb0175","doi-asserted-by":"crossref","first-page":"15600","DOI":"10.1074\/jbc.M111142200","article-title":"Insulin-like growth factor I induces MDM2-dependent degradation of p53 via the p38 MAPK pathway in response to DNA damage","volume":"277","author":"Heron-Milhavet","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2014.03.006_bb0180","doi-asserted-by":"crossref","first-page":"8247","DOI":"10.1073\/pnas.1431613100","article-title":"Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor","volume":"100","author":"Girnita","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ghir.2014.03.006_bb0185","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/scbi.1998.0097","article-title":"Regulation of p53 downstream genes","volume":"8","author":"el-Deiry","year":"1998","journal-title":"Semin. Cancer Biol"},{"key":"10.1016\/j.ghir.2014.03.006_bb0190","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ghir.2005.07.005","article-title":"The p53-family members p63 and p73 inhibit insulin-like growth factor-I receptor gene expression in colon cancer cells","volume":"15","author":"Nahor","year":"2005","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2014.03.006_bb0195","doi-asserted-by":"crossref","first-page":"e537","DOI":"10.1016\/S1470-2045(12)70362-5","article-title":"IGF-1 and BRCA1 signalling pathways in familial cancer","volume":"13","author":"Werner","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ghir.2014.03.006_bb0200","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.mce.2006.03.018","article-title":"Transcriptional regulation of the insulin-like growth factor-I receptor gene in breast cancer","volume":"252","author":"Sarfstein","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ghir.2014.03.006_bb0205","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-5793(03)00315-6","article-title":"BRCA1\u2013Sp1 interactions in transcriptional regulation of the IGF-IR gene","volume":"541","author":"Abramovitch","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ghir.2014.03.006_bb0210","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1006\/mgme.1999.2958","article-title":"BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: potential interaction between BRCA1 and Sp1","volume":"69","author":"Maor","year":"2000","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ghir.2014.03.006_bb0215","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.canlet.2007.07.019","article-title":"Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations","volume":"257","author":"Maor","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ghir.2014.03.006_bb0220","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1055\/s-2004-814154","article-title":"Functional and physical interactions between BRCA1 and p53 in transcriptional regulation of the IGF-IR gene","volume":"35","author":"Abramovitch","year":"2003","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ghir.2014.03.006_bb0225","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/IGC.0b013e318254011f","article-title":"BRCA1 is expressed in uterine serous carcinoma (USC) and controls insulin-like growth factor I receptor (IGF-IR) gene expression in USC cell lines","volume":"22","author":"Amichay","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ghir.2014.03.006_bb0230","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1158\/1078-0432.CCR-08-1440","article-title":"Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner","volume":"15","author":"Schayek","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ghir.2014.03.006_bb0235","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1055\/s-2007-970415","article-title":"Insulin-like growth factor-I controls BRCA1 gene expression through activation of transcription factor Sp1","volume":"39","author":"Maor","year":"2007","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ghir.2014.03.006_bb0240","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(90)90601-A","article-title":"Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus","volume":"60","author":"Call","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.ghir.2014.03.006_bb0245","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/343774a0","article-title":"Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping","volume":"343","author":"Gessler","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2014.03.006_bb0250","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/sj.leu.2403817","article-title":"Wilms' tumour gene 1 (WT1) in human neoplasia","volume":"19","author":"Keilholz","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.ghir.2014.03.006_bb0255","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1128\/MCB.15.7.3516","article-title":"Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression","volume":"15","author":"Werner","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ghir.2014.03.006_bb0260","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1210\/en.2003-0400","article-title":"The WT1 Wilms' tumor suppressor gene: a novel target for insulin-like growth factor-I action","volume":"144","author":"Bentov","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2014.03.006_bb0265","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1038\/sj.onc.1210474","article-title":"The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma","volume":"26","author":"Yuen","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ghir.2014.03.006_bb0270","first-page":"2837","article-title":"Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor","volume":"54","author":"Ladanyi","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.ghir.2014.03.006_bb0275","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1038\/sj.onc.1205042","article-title":"Transcriptional regulation of IGF-I receptor gene expression by novel isoforms of the EWS\u2013WT1 fusion protein","volume":"21","author":"Finkeltov","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.ghir.2014.03.006_bb0280","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.canlet.2006.03.027","article-title":"A novel EWS\u2013WT1 gene fusion product in desmoplastic small round cell tumor is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene","volume":"247","author":"Werner","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ghir.2014.03.006_bb0285","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1074\/jbc.M111.281782","article-title":"Insulin-like growth factor-I receptor (IGF-IR) translocates to nucleus and autoregulates IGF-IR gene expression in breast cancer cells","volume":"287","author":"Sarfstein","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2014.03.006_bb0290","doi-asserted-by":"crossref","first-page":"ra10","DOI":"10.1126\/scisignal.2000628","article-title":"SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor","volume":"3","author":"Sehat","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ghir.2014.03.006_bb0295","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1158\/0008-5472.CAN-10-0052","article-title":"Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells","volume":"70","author":"Aleksic","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ghir.2014.03.006_bb0300","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1210\/en.2012-2165","article-title":"Minireview: nuclear insulin and insulin-like growth factor-1 receptors: a novel paradigm in signal transduction","volume":"154","author":"Sarfstein","year":"2013","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.ghir.2014.03.006_bb0305","doi-asserted-by":"crossref","first-page":"e42483","DOI":"10.1371\/journal.pone.0042483","article-title":"Novel nuclear localization and potential function of insulin-like growth factor-1 receptor\/insulin receptor hybrid in corneal epithelial cells","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ghir.2014.03.006_bb0310","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/ng0794-433","article-title":"Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour","volume":"7","author":"Steenman","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ghir.2014.03.006_bb0315","doi-asserted-by":"crossref","first-page":"9014","DOI":"10.1074\/jbc.271.15.9014","article-title":"Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor","volume":"271","author":"Vu","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2014.03.006_bb0320","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/39631","article-title":"Imprinted expression of the Igf2r gene depends on an intronic CpG island","volume":"389","author":"Wutz","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2014.03.006_bb0325","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.yexcr.2010.03.007","article-title":"Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene","volume":"316","author":"Schayek","year":"2010","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ghir.2014.03.006_bb0330","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.mce.2010.04.017","article-title":"Differential regulation of insulin-like growth factor-I receptor gene expression by wild type and mutant androgen receptor in prostate cancer cells","volume":"323","author":"Schayek","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ghir.2014.03.006_bb0335","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1055\/s-0032-1311566","article-title":"Global methylation analysis identifies PITX2 as an upstream regulator of the androgen receptor and IGF-I receptor genes in prostate cancer","volume":"44","author":"Schayek","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ghir.2014.03.006_bb0340","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4161\/epi.6.4.14791","article-title":"Epigenetic DNA methylation in the promoters of the Igf1 receptor and insulin receptor genes in db\/db mice","volume":"6","author":"Nikoshkov","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.ghir.2014.03.006_bb0345","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.ghir.2014.03.006_bb0350","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrc2715","article-title":"p53 and metabolism","volume":"9","author":"Vousden","year":"2009","journal-title":"Nat. Rev. Cancer"}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637414202425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637414202425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:47:58Z","timestamp":1761086878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637414202425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1096637414202425"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2014.03.006","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptional and epigenetic control of IGF1R gene expression: Implications in metabolism and cancer","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2014.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}